World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
43
Citations
8119
World Ranking
4833
National Ranking
403

Brian J. Willett publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Brian J. Willett sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 177 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Brian J. Willett D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Brian J. Willett sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 43 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Brian J. Willett is affiliated with the University of Glasgow in the United Kingdom and conducts research primarily in the field of Medicine. Their work covers several subfields including Infectious Diseases, Animal Science and Zoology, Genetics, Epidemiology, and Virology.

The main topics of Brian J. Willett's research include:

  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Vectors
  • Animal Virus Infections Studies
  • COVID-19 Clinical Research Studies
  • Virus-based Gene Therapy Research
  • Virology and Viral Diseases
  • SARS-CoV-2 detection and testing

Brian J. Willett has published extensively across multiple venues, with a notable concentration of publications in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Viruses
  • SSRN Electronic Journal
  • Scientific Reports
  • Nature Microbiology

Recent published papers of Brian J. Willett include:

  • "SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway" (2022, Nature Microbiology)
  • "SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies" (2022, Nature Reviews Microbiology)
  • "Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection" (2021, Nature Immunology)
  • "Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination" (2021, PLoS Pathogens)
  • "In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2" (2021, PLoS Pathogens)

Coauthors frequently collaborating with Willett include:

  • Nicola Logan
  • Emma C. Thomson
  • Christopher Davis
  • Sam Scott
  • Pablo R. Murcia

Best Publications

  • SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

    Unknown

  • SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies

    Unknown

  • The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism

    Unknown

  • FIV infection of the domestic cat: an animal model for AIDS

    B J Willett;J N Flynn;M J Hosie

  • Use of CD134 as a primary receptor by the feline immunodeficiency virus.

    Masayuki Shimojima;Takayuki Miyazawa;Takayuki Miyazawa;Yasuhiro Ikeda;Elizabeth L. McMonagle

  • Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.

    Brian J. Willett;Laurent Picard;Margaret J. Hosie;Julie D. Turner

  • Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection

    Unknown

  • Dynamics of a morbillivirus at the domestic–wildlife interface: Canine distemper virus in domestic dogs and lions

    Mafalda Viana;Sarah Cleaveland;Jason Matthiopoulos;Jo Halliday

  • Host and Viral Determinants of Mx2 Antiretroviral Activity

    Idoia Busnadiego;Melissa Kane;Suzannah J. Rihn;Hannah F. Preugschas

  • A Putative Cell Surface Receptor for Anemia-Inducing Feline Leukemia Virus Subgroup C Is a Member of a Transporter Superfamily

    Chetankumar S. Tailor;Brian J. Willett;David Kabat

  • Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.

    Chris Davis;Nicola Logan;Grace Tyson;Richard Orton

  • In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2.

    Agnieszka M Szemiel;Andres Merits;Richard J Orton;Oscar A MacLean

  • Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation

    Andrew R.E. Shaw;Agatha Domanska;Allan Mak;Anita Gilchrist

  • Effect of Mutations in the Second Extracellular Loop of CXCR4 on Its Utilization by Human and Feline Immunodeficiency Viruses

    Anne Brelot;Nikolaus Heveker;Karen Adema;Margaret J. Hosie

  • Histologic Classification and Immunophenotype of Lymphosarcomas in Cats with Naturally and Experimentally Acquired Feline Immunodeficiency Virus Infections

    J. J. Callanan;B. A. Jones;J. Irvine;B. J. Willett

  • Feline leukaemia virus: half a century since its discovery.

    Brian J. Willett;Margaret J. Hosie

  • Common mechanism of infection by lentiviruses

    Brian J. Willett;Margaret J. Hosie;James C. Neil;Julie D. Turner

  • Clinical and pathological findings in feline immunodeficiency virus experimental infection

    J.J. Callanan;H. Thompson;S.R. Toth;B. O'Neil

  • SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

    Unknown

  • DNA Vaccination Affords Significant Protection against Feline Immunodeficiency Virus Infection without Inducing Detectable Antiviral Antibodies

    Margaret J. Hosie;J. Norman Flynn;Mark A. Rigby;Celia Cannon

  • Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset.

    B J Willett;M J Hosie;J J Callanan;J C Neil

  • Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4.

    Brian J. Willett;Margaret J. Hosie;Tom H. Dunsford;James C. Neil

  • Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding.

    A de Parseval;D L Lerner;P Borrow;B J Willett

  • A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor.

    M J Hosie;B J Willett;T H Dunsford;O Jarrett

  • Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9.

    B J Willett;M J Hosie;O Jarrett;J C Neil

Frequent Co-Authors

Margaret J Hosie
Margaret J Hosie University of Glasgow
Oswald Jarrett
Oswald Jarrett University of Glasgow
James C. Neil
James C. Neil University of Glasgow
Sarah Cleaveland
Sarah Cleaveland University of Glasgow
Massimo Palmarini
Massimo Palmarini University of Glasgow
Vivek Kapur
Vivek Kapur Pennsylvania State University
Arvind H. Patel
Arvind H. Patel University of Glasgow
Peter J. Hudson
Peter J. Hudson Pennsylvania State University
David Robertson
David Robertson Vanderbilt University
Ottar N. Bjørnstad
Ottar N. Bjørnstad Pennsylvania State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, several related healthcare degrees offer exciting career pathways. Nursing professions, such as Licensed Practical Nurse (LPN) programs, serve as excellent entry points. Many students seek out lpn schools easy to get into to quickly start their healthcare journey while building foundational immunology knowledge.

Advancing from LPN, aspiring healthcare providers often consider nurse practitioner roles. Identifying which nurse practitioner program is easiest can help students select programs that balance rigorous training with accessibility.

For those drawn to mental health within immunology, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs offer specialized clinical training. Many look for the best pmhnp programs to ensure strong clinical placement and practical experience.

Cost is also a significant factor. Exploring the cheapest online pmhnp certificate programs allows students to pursue quality education without excessive financial burden.

Understanding these pathways can help immunology students align their education with long-term career goals in healthcare and research.

Best Scientists Citing Brian J. Willett

Trending Scientists

Recently Published Articles